Nexmos is an innovative, biotechnology R&D company with a brand new DNA meta- platform protected by global intellectual properties. Founded in 2014, the company has mainly developed DNA-based Aptamer technology with registered related patents and worked in the healthcare and therapeutics industry using its technology

Nexmos believes that innovation is the key to improving humanity's life. Nexmos bio-experts are dedicated to solving degenerative brain diseases with new drugs and treatments and continually expanding more diverse industries such as skincare, F&B, etc. We are constantly striving that more people can enjoy the benefits of the DNA substance Aptamin® platforms. Nexmos always try to answer humanity's quest and make a world difference